MMP11 is associated with the immune response and immune microenvironment in EGFR-mutant lung adenocarcinoma

MMP11 is associated with the immune response and immune microenvironment in EGFR-mutant lung adenocarcinoma

BackgroundHigh expression of matrix metalloproteinase-11 (MMP11) is associated with various tumors and immune microenvironments. Conversely, poor response to immunotherapy in epidermal growth factor receptor (EGFR)-mutant lung adenocarcinoma (LUAD) patients is closely related to the characteristics...

Full description

Bibliographic Details
Main Authors:	Lu Bai, Ran Huo, Guotao Fang, Tiantian Ma, Yanhong Shang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-01-01
Series:	Frontiers in Oncology
Subjects:	matrix metalloproteinase 11 (MMP11) lung adenocarcinoma epidermal growth factor receptor (EGFR) immune microenvironment immunotherapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1055122/full

Similar Items

Exploration of the Tumor-Suppressive Immune Microenvironment by Integrated Analysis in EGFR-Mutant Lung Adenocarcinoma
by: Teng Li, et al.
Published: (2021-05-01)

Serum levels of MMP-11 correlate with clinical outcome in Chinese patients with advanced gastric adenocarcinoma
by: Liu Jin-Wei, et al.
Published: (2011-04-01)

Immune Microenvironment Comparation Study between EGFR Mutant and EGFR Wild Type Lung Adenocarcinoma Patients Based on TCGA Database
by: Guangsheng ZHU, et al.
Published: (2021-04-01)

MMP-11 expression in early luminal breast cancer: associations with clinical, MRI, pathological characteristics, and disease-free survival
by: Sébastien Molière, et al.
Published: (2024-03-01)

GDF-11 promotes human trophoblast cell invasion by increasing ID2-mediated MMP2 expression
by: Ze Wu, et al.
Published: (2022-06-01)

Favorable Immune Microenvironment in Patients with EGFR and MAPK Co-Mutations
by: Yang W, et al.
Published: (2020-09-01)

Correlation between Immune Microenvironment Features and EGFR Mutation Status  in Lung Adenocarcinoma
by: Hongyu ZHU, et al.
Published: (2023-03-01)

Influence of the Timing of Leptomeningeal Metastasis on the Outcome of <i>EGFR</i>-Mutant Lung Adenocarcinoma Patients and Predictors of Detectable <i>EGFR</i> Mutations in Cerebrospinal Fluid
by: Pei-Ya Liao, et al.
Published: (2022-06-01)

A real-world study comparing perioperative chemotherapy and EGFR-tyrosine kinase inhibitors for treatment of resected stage III EGFR-mutant adenocarcinoma
by: Chieh-Lung Chen, et al.
Published: (2023-09-01)

Impact of Deoxycholic Acid on Oesophageal Adenocarcinoma Invasion: Effect on Matrix Metalloproteinases
by: Fran Quilty, et al.
Published: (2020-10-01)

Prognostic Analysis of EGFR-TKIs Combined with Gamma Knife in EGFR-mutant Lung Adenocarcinoma with Brain Metastasis
by: Limin CHEN, et al.
Published: (2019-05-01)

The clinicopathological and molecular characteristics of resected EGFR‐mutant lung adenocarcinoma
by: Wensheng Zhou, et al.
Published: (2022-03-01)

Plasma Concentrations of Matrilysins MMP-7 and MMP-26 as Diagnostic Biomarkers in Breast Cancer
by: Barbara Maria Piskór, et al.
Published: (2021-04-01)

Activity of MMP-2, MMP-8 and MMP-9 in serum as a marker of progression of alcoholic liver disease in people from Lublin Region, eastern Poland
by: Andrzej Prystupa, et al.
Published: (2015-05-01)

Expression of metalloproteinases MMP-2 and MMP-9 is associated to the presence of androgen receptor in epithelial ovarian tumors
by: Flavia Morales-Vásquez, et al.
Published: (2020-07-01)

Relationship between MMP-11 Expression in Invasive Ductal Breast Carcinoma with its Clinicopathologic Parameters
by: Farshad Naghshvar, et al.
Published: (2017-04-01)

Matrix Metalloproteinase Genes (<i>MMP1, MMP10, MMP12</i>) on Chromosome 11q22 and the Risk of Non-Contact Anterior Cruciate Ligament Ruptures
by: Ewelina Lulińska, et al.
Published: (2020-07-01)

Emerging Role of EGFR Mutations in Creating an Immune Suppressive Tumour Microenvironment
by: Simran S. Kapoor, et al.
Published: (2021-12-01)

Outcomes of salvage lung resections in advanced EGFR‐mutant lung adenocarcinomas under EGFR TKIs
by: Ying‐Yuan Chen, et al.
Published: (2021-10-01)

EGFR DNA Methylation Correlates With EGFR Expression, Immune Cell Infiltration, and Overall Survival in Lung Adenocarcinoma
by: Zhanyu Xu, et al.
Published: (2021-08-01)

Prognostic analysis of patients with mutant and wild-type EGFR gene lung adenocarcinoma
by: Zheng H, et al.
Published: (2019-07-01)

An inverse interaction between HOXA11 and HOXA11-AS is associated with cisplatin resistance in lung adenocarcinoma
by: Youwei Zhang, et al.
Published: (2019-10-01)

Elevated murine HB-EGF confers sensitivity to diphtheria toxin in EGFR-mutant lung adenocarcinoma
by: Camila Robles-Oteiza, et al.
Published: (2021-11-01)

Fusing WGCNA and Machine Learning for Immune-Related Gene Prognostic Index in Lung Adenocarcinoma: Precision Prognosis, Tumor Microenvironment Profiling, and Biomarker Discovery
by: He J, et al.
Published: (2023-11-01)

MMP-7 is upregulated by COX-2 and promotes proliferation and invasion of lung adenocarcinoma cells
by: J. Zhang, et al.
Published: (2014-02-01)

ITGA11, a Prognostic Factor Associated with Immunity in Gastric Adenocarcinoma
by: Yang X, et al.
Published: (2024-02-01)

Associations of <i>TIMP-3</i> Genetic Polymorphisms with <i>EGFR</i> Statuses and Cancer Clinicopathologic Development in Lung Adenocarcinoma Patients
by: Jer-Hwa Chang, et al.
Published: (2020-10-01)

Novel Roles of MT1-MMP and MMP-2: Beyond the Extracellular Milieu
by: Deanna V. Maybee, et al.
Published: (2022-08-01)

Dynamic Expression of Membrane Type 1-Matrix Metalloproteinase (Mt1-mmp/Mmp14) in the Mouse Embryo
by: Emma Muñoz-Sáez, et al.
Published: (2021-09-01)

MicroRNA‐125b as a tumor suppressor by targeting MMP11 in breast cancer
by: Yanan Wang, et al.
Published: (2020-06-01)

Differential Expression of EGFR-1, MMP-3, and MMP-9 in Spontaneous Abortions, Induced Abortions, and Tubal Pregnancies
by: Mahi BALCI, et al.
Published: (2019-01-01)

Combination therapy of brain radiotherapy and EGFR-TKIs is more effective than TKIs alone for EGFR-mutant lung adenocarcinoma patients with asymptomatic brain metastasis
by: Yanxin Chen, et al.
Published: (2019-08-01)

Integrative stemness characteristics associated with prognosis and the immune microenvironment in lung adenocarcinoma
by: Han Wang, et al.
Published: (2022-12-01)

Limited Benefit from the Addition of Immunotherapy to Chemotherapy in TKI-Refractory EGFR-Mutant Lung Adenocarcinoma
by: Lingzhi Hong, et al.
Published: (2022-07-01)

The relationship between metastasis and mmp-9 in sheep with pulmonary adenocarcinomas
by: Emin KARAKURT, et al.
Published: (2022-03-01)

Biodistribution of 99mTc-GE11 molecular probe and receptor imaging in nude mice bearing lung adenocarcinoma
by: TAN Zuwen, et al.
Published: (2019-07-01)

Immune profiles according to EGFR mutant subtypes and correlation with PD-1/PD-L1 inhibitor therapies in lung adenocarcinoma
by: Young Wha Koh, et al.
Published: (2023-03-01)

The Role of MMP-9 and MMP-9 Inhibition in Different Types of Thyroid Carcinoma
by: Zhenshengnan Li, et al.
Published: (2023-04-01)

Integrative analysis identifies CXCL11 as an immune-related prognostic biomarker correlated with cell proliferation and immune infiltration in multiple myeloma microenvironment
by: Huizhong Wang, et al.
Published: (2022-05-01)

Loss of MT1-MMP in Alveolar Epithelial Cells Exacerbates Pulmonary Fibrosis
by: Luis Placido, et al.
Published: (2021-03-01)